Publications and Awards
Molecular Cancer Therapeutics 2015
MEK Inhibitor Selumetinib Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.
Journal of Cancer 2015
2D and 3D RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor for Combination Treatment of TNBC.
Molecular Cancer Therapeutics 2013
phosphoPEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.
High ERK protein expression levels correlate with shorter survival in triple negative breast cancer patients.
Honors and Awards
2016 - Chandra Bartholomeusz, M.D., Ph.D.
MD Anderson Institutional Research Grant
2016 - Mary Kathryn Pitner, Ph.D.
AACR Scholar in Training Award, The Triple Negative Breast Cancer Foundation
2016 - Mary Kathryn Pitner, Ph. D.
MD Anderson Endowed Fellowship Award, The Sheskey Family Foundation for Breast Cancer Research